Page last updated: 2024-09-02

tephrosin and Acute Lung Injury

tephrosin has been researched along with Acute Lung Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, X; Tian, H; Yang, J	1

Other Studies

1 other study(ies) available for tephrosin and Acute Lung Injury

Article	Year
Tephrosin attenuates sepsis induced acute lung injury in rats by impeding expression of ICAM-1 and MIP-2. Microbial pathogenesis, 2018, Volume: 117 Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cecum; Chemokine CXCL2; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Intercellular Adhesion Molecule-1; Lung; Lung Injury; Lymphocyte Count; Male; Neutrophils; Protective Agents; Rats; Rats, Sprague-Dawley; Rotenone; Sepsis	2018

Article

Year

Tephrosin attenuates sepsis induced acute lung injury in rats by impeding expression of ICAM-1 and MIP-2.

Microbial pathogenesis, 2018, Volume: 117

Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cecum; Chemokine CXCL2; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Intercellular Adhesion Molecule-1; Lung; Lung Injury; Lymphocyte Count; Male; Neutrophils; Protective Agents; Rats; Rats, Sprague-Dawley; Rotenone; Sepsis

2018